Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Aug;28(8):1008–1012. doi: 10.1136/gut.28.8.1008

Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.

S A Riley 1, J Lecarpentier 1, V Mani 1, M J Goodman 1, B K Mandal 1, L A Turnberg 1
PMCID: PMC1433131  PMID: 2889648

Abstract

Seminal abnormalities are commonly found during sulphasalazine treatment. Although these changes appear reversible after drug withdrawal this may result in colitis relapse. Animal studies suggest that 5-aminosalicylic acid, the active component of sulphasalazine, does not impair fertility. Sixteen patients with quiescent ulcerative colitis were studied. Each patient produced three samples of semen at weekly intervals. Of the 48 samples analysed 39.6% showed oligospermia, 41.7% showed an increased number of abnormal forms and 91.7% showed impaired motility. Nine patients substituted enteric coated mesalazine (5-aminosalicylic acid) for sulphasalazine for a minimum period of three months. During this time one patient developed a salmonella associated colitis relapse; the others remained well. Improvement in sperm count (p less than 0.02), motility (p less than 0.001) and morphology (p less than 0.02) occurred in all cases. To date, four successful pregnancies have resulted, three in couples complaining of long term infertility. Treatment with enteric-coated mesalazine allows the recovery of seminal abnormalities induced by sulphasalazine in patients with colitis.

Full text

PDF
1008

Images in this article

1010Fig. 2
on p.1010

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azad Khan A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977 Oct 29;2(8044):892–895. doi: 10.1016/s0140-6736(77)90831-5. [DOI] [PubMed] [Google Scholar]
  2. BARON J. H., CONNELL A. M., LENNARD-JONES J. E., JONES F. A. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet. 1962 May 26;1(7239):1094–1096. doi: 10.1016/s0140-6736(62)92080-9. [DOI] [PubMed] [Google Scholar]
  3. Birnie G. G., McLeod T. I., Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut. 1981 Jun;22(6):452–455. doi: 10.1136/gut.22.6.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet. 1981 Aug 8;2(8241):270–271. doi: 10.1016/s0140-6736(81)90523-7. [DOI] [PubMed] [Google Scholar]
  5. Cann P. A., Holdsworth C. D. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid. Lancet. 1984 May 19;1(8386):1119–1119. doi: 10.1016/s0140-6736(84)92526-1. [DOI] [PubMed] [Google Scholar]
  6. Chan R. P., Pope D. J., Gilbert A. P., Sacra P. J., Baron J. H., Lennard-Jones J. E. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci. 1983 Jul;28(7):609–615. doi: 10.1007/BF01299921. [DOI] [PubMed] [Google Scholar]
  7. Collen M. J. Azulfidine-induced oligospermia. Am J Gastroenterol. 1980 Nov;74(5):441–442. [PubMed] [Google Scholar]
  8. Das K. M., Eastwood M. A., McManus J. P., Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med. 1973 Sep 6;289(10):491–495. doi: 10.1056/NEJM197309062891001. [DOI] [PubMed] [Google Scholar]
  9. Dew M. J., Harries A. D., Evans B. K., Rhodes J. Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet. 1983 Oct 1;2(8353):801–801. doi: 10.1016/s0140-6736(83)92341-3. [DOI] [PubMed] [Google Scholar]
  10. Dew M. J., Hughes P. J., Lee M. G., Evans B. K., Rhodes J. An oral preparation to release drugs in the human colon. Br J Clin Pharmacol. 1982 Sep;14(3):405–408. doi: 10.1111/j.1365-2125.1982.tb01999.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dew M. J., Hughes P., Harries A. D., Williams G., Evans B. K., Rhodes J. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) 1982 Oct 9;285(6347):1012–1012. doi: 10.1136/bmj.285.6347.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dew M. J., Ryder R. E., Evans N., Evans B. K., Rhodes J. Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol. 1983 Aug;16(2):185–187. doi: 10.1111/j.1365-2125.1983.tb04983.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dissanayake A. S., Truelove S. C. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut. 1973 Dec;14(12):923–926. doi: 10.1136/gut.14.12.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Freeman J. G., Reece V. A., Venables C. W. Sulphasalazine and spermatogenesis. Digestion. 1982;23(1):68–71. doi: 10.1159/000198712. [DOI] [PubMed] [Google Scholar]
  15. Goldman P. Will there be a next generation of sulfasalazine? Gastroenterology. 1982 Nov;83(5):1138–1141. [PubMed] [Google Scholar]
  16. Grieve J. Male infertility due to sulphasalazine. Lancet. 1979 Sep 1;2(8140):464–464. doi: 10.1016/s0140-6736(79)91512-5. [DOI] [PubMed] [Google Scholar]
  17. HELLER C. H., CLERMONT Y. KINETICS OF THE GERMINAL EPITHELIUM IN MAN. Recent Prog Horm Res. 1964;20:545–575. [PubMed] [Google Scholar]
  18. Haagen Nielsen O., Bondesen S. Kinetics of 5-aminosalicylic acid after jejunal instillation in man. Br J Clin Pharmacol. 1983 Dec;16(6):738–740. doi: 10.1111/j.1365-2125.1983.tb02254.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hrudka F., Singh A. Sperm nucleomalacia in men with inflammatory bowel disease. Arch Androl. 1984;13(1):37–57. doi: 10.3109/01485018408987499. [DOI] [PubMed] [Google Scholar]
  20. Hudson E., Doré C., Sowter C., Toovey S., Levi A. J. Sperm size in patients with inflammatory bowel disease on sulfasalazine therapy. Fertil Steril. 1982 Jul;38(1):77–84. doi: 10.1016/s0015-0282(16)46399-5. [DOI] [PubMed] [Google Scholar]
  21. Klotz U., Maier K., Fischer C., Heinkel K. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N Engl J Med. 1980 Dec 25;303(26):1499–1502. doi: 10.1056/NEJM198012253032602. [DOI] [PubMed] [Google Scholar]
  22. LENNARD-JONES J. E., LONGMORE A. J., NEWELL A. C., WILSON C. W., JONES F. A. An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut. 1960 Sep;1:217–222. doi: 10.1136/gut.1.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Levi A. J., Fisher A. M., Hughes L., Hendry W. F. Male infertility due to sulphasalazine. Lancet. 1979 Aug 11;2(8137):276–278. doi: 10.1016/s0140-6736(79)90292-7. [DOI] [PubMed] [Google Scholar]
  24. McIntyre P. B., Lennard-Jones J. E. Reversal with balsalazide of infertility caused by sulphsalazine. Br Med J (Clin Res Ed) 1984 Jun 2;288(6431):1652–1653. doi: 10.1136/bmj.288.6431.1652-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'Moráin C., Smethurst P., Doré C. J., Levi A. J. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut. 1984 Oct;25(10):1078–1084. doi: 10.1136/gut.25.10.1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Peppercorn M. A., Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther. 1972 Jun;181(3):555–562. [PubMed] [Google Scholar]
  27. Schröder H., Evans D. A. Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Gut. 1972 Apr;13(4):278–284. doi: 10.1136/gut.13.4.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schwartz D., Mayaux M. J., Guihard-Moscato M. L., Spira A., Jouannet P., Czyglik F., David G. Study of sperm morphologic characteristics in a group of 833 fertile men. Andrologia. 1984 Sep-Oct;16(5):423–428. doi: 10.1111/j.1439-0272.1984.tb00389.x. [DOI] [PubMed] [Google Scholar]
  29. Shaffer J. L., Kershaw A., Berrisford M. H. Sulphasalazine-induced infertility reversed on transfer to 5-aminosalicylic acid. Lancet. 1984 Jun 2;1(8388):1240–1240. doi: 10.1016/s0140-6736(84)91724-0. [DOI] [PubMed] [Google Scholar]
  30. Toovey S., Hudson E., Hendry W. F., Levi A. J. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut. 1981 Jun;22(6):445–451. doi: 10.1136/gut.22.6.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril. 1979 May;31(5):538–540. doi: 10.1016/s0015-0282(16)44000-8. [DOI] [PubMed] [Google Scholar]
  32. van Hees P. A., Bakker J. H., van Tongeren J. H. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. Gut. 1980 Jul;21(7):632–635. doi: 10.1136/gut.21.7.632. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES